Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Emanuele Durante-Mangoni, Alessandro Riccardi, Mario Guarino, Flavio Cesaro, Marina Lugarà, Silvia Mascolo, Lucia Morelli, Vincenzo Natale & Massimo Andreoni. (2023) Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol. Journal of Chemotherapy 35:5, pages 397-403.
Read now
Read now
Alessandra Oliva, Sergio Carbonara, Vito Cianci, Massimo Crapis, Enea Gino Di Domenico, Marco Falcone, Gioacchino Galardo, Emanuele Durante-Mangoni & Mario Venditti. (2023) Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin. Expert Review of Anti-infective Therapy 21:7, pages 703-721.
Read now
Read now
Gabriele Sganga, Federico Pea, Domenico Aloj, Silvia Corcione, Marina Pierangeli, Stefania Stefani, Gian Maria Rossolini & Francesco Menichetti. (2020) Acute wound infections management: the ‘Don’ts’ from a multidisciplinary expert panel. Expert Review of Anti-infective Therapy 18:3, pages 231-240.
Read now
Read now
A. Marcellusi, R. Viti, P. Sciattella, L. Sarmati, A. Streinu-Cercel, A. Pana, J. Espin, J. P. Horcajada, G. Favato, D. Andretta, M. Soro, M. Andreoni & F. S. Mennini. (2019) Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries. Expert Review of Pharmacoeconomics & Outcomes Research 19:5, pages 581-599.
Read now
Read now
Katelyn R. Keyloun, Eric Lofgren & Scott Hebert. (2019) Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department. Journal of Medical Economics 22:7, pages 652-661.
Read now
Read now
Katelyn R. Keyloun, David J. Weber, Betsey M. Gardstein, Ariel Berger, Patrick Gillard & Michael L. Ganz. (2018) Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States. Hospital Practice 46:5, pages 278-286.
Read now
Read now
S. S. Almarzoky Abuhussain, K. J. Goodlet, M. D. Nailor & D. P. Nicolau. (2018) Optimizing skin and skin structure infection outcomes: considerations of cost of care. Expert Review of Pharmacoeconomics & Outcomes Research 18:3, pages 235-244.
Read now
Read now
Neil J Turco, Sandra L Kane-Gill, Inmaculada Hernandez, Louise-Marie Oleksiuk, Frank D’Amico & Aaron J Pickering. (2018) A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections. Expert Opinion on Pharmacotherapy 19:4, pages 319-325.
Read now
Read now
Eliane Molina Psaltikidis, Everton Nunes da Silva, Joaquim Murray Bustorff-Silva, Maria Luiza Moretti & Mariângela Ribeiro Resende. (2017) Economic evaluation of outpatient parenteral antimicrobial therapy: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 17:4, pages 355-375.
Read now
Read now
Articles from other publishers (38)
Thomas P. LodiseKyle GunterFan MuEmily GaoDanni YangErica YimSteve SandorGail Berman. (2023) Real-world effectiveness of omadacycline and impact of unapproved omadacycline prescription claims among adult outpatients with community-acquired bacterial pneumonia or acute bacterial skin and skin structure infections. Journal of Managed Care & Specialty Pharmacy 29:8, pages 952-964.
Crossref
Crossref
Kyle A. Weant & Haili Gregory. (2023) The Potential Utility of Single-Dose Long-Acting Intravenous Antibiotics for Acute Bacterial Skin and Skin-Structure Infections in the Emergency Department. Advanced Emergency Nursing Journal 45:3, pages 177-186.
Crossref
Crossref
Christoph T. Baltin, Carolin Wulf, Robert Rongisch, Clara Lehmann, Sebastian Wingen-Heimann, Nicole Eisenmenger, Jennifer Bonn, Mario Fabri, Esther von Stebut, Oliver A. Cornely & Florian Kron. (2023) Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis. Journal of Infection and Public Health 16:6, pages 955-963.
Crossref
Crossref
Abby C. Bradley, Mary Joyce B. Wingler, Katherine L. Artman, Lori M. Ward & Jose Lucar. (2023) An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy. Therapeutic Advances in Infectious Disease 10.
Crossref
Crossref
Connor Evins, Harrison Lancaster & Amanda E. Schnee. (2022) Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series. Annals of Clinical Microbiology and Antimicrobials 21:1.
Crossref
Crossref
Daniela Zinzi, Ioanna Vlachaki, Edel Falla, Theo Mantopoulos & Dilip Nathwani. (2022) Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective. The European Journal of Health Economics 23:8, pages 1371-1381.
Crossref
Crossref
Gavin Barlow, Michael Wilke & Guillaume Béraud. (2022) Tackling Extended Hospital Stays in Patients with Acute Bacterial Skin and Skin Structure Infections. European Medical Journal, pages 76-85.
Crossref
Crossref
Alpesh N. Amin, E. Patchen Dellinger, Glenn Harnett, Bryan D. Kraft, Kerry L. LaPlante, Frank LoVecchio, James A. McKinnell, Glenn Tillotson & Salisia Valentine. (2022) It’s about the patients: Practical antibiotic stewardship in outpatient settings in the United States. Frontiers in Medicine 9.
Crossref
Crossref
Julia Gonzalez, Diana Carolina Andrade & JianLi Niu. (2021) Cost-Consequence Analysis of Single-Dose Dalbavancin Versus Standard of Care for the Treatment of Acute Bacterial Skin and Skin Structure Infections in a Multisite Healthcare System. Clinical Infectious Diseases 73:7, pages e1436-e1442.
Crossref
Crossref
Christopher C. CooperGary E. SteinSubhashis MitraAhmed AbubakerDaniel H. Havlichek. (2021) Long-Acting Lipoglycopeptides for the Treatment of Bone and Joint Infections. Surgical Infections 22:8, pages 771-779.
Crossref
Crossref
Arjun V. Jogimahanti, Ashwini T. Kini, Lauren E. Irwin & Andrew G. Lee. (2021) The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis. Journal of Neuro-Ophthalmology 41:3, pages 342-350.
Crossref
Crossref
Frederick Robert Carrick, Luis Sebastian Alexis Valerio, Maxine N. Gonzalez-Vega, David Engel & Kiminobu Sugaya. (2021) Accelerated Wound Healing Using a Novel Far-Infrared Ceramic Blanket. Life 11:9, pages 878.
Crossref
Crossref
Marco Falcone, Juris J Meier, Maria Giulia Marini, Riccardo Caccialanza, José María Aguado, Stefano Del Prato & Francesco Menichetti. (2021) Diabetes and acute bacterial skin and skin structure infections. Diabetes Research and Clinical Practice 174, pages 108732.
Crossref
Crossref
Christian Koziatek, Noah Klein, Sanjay Mohan, Viraj Lakdawala, Jordan Swartz, Robert Femia, Robert Press & Christopher Caspers. (2021) Use of a telehealth follow-up system to facilitate treatment and discharge of emergency department patients with severe cellulitis. The American Journal of Emergency Medicine 41, pages 184-189.
Crossref
Crossref
Alex Soriano, Stefania Stefani, Mathias W. Pletz & Francesco Menichetti. (2020) Antimicrobial stewardship in patients with acute bacterial skin and skin-structure infections: An international Delphi consensus. Journal of Global Antimicrobial Resistance 22, pages 296-301.
Crossref
Crossref
Sandy Estrada, Thomas P. Lodise, Glenn S. Tillotson & Dino Delaportas. (2020) The Real-World Economic and Clinical Management of Adult Patients with Skin and Soft Tissue Infections (SSTIs) with Oritavancin: Data from Two Multicenter Observational Cohort Studies. Drugs - Real World Outcomes 7:S1, pages 6-12.
Crossref
Crossref
Martin Krsak, Taylor Morrisette, Matthew Miller, Kyle Molina, Misha Huang, Laura Damioli, Larissa Pisney, Megan Wong & Eric Poeschla. (2020) Advantages of Outpatient Treatment with Long‐Acting Lipoglycopeptides for Serious Gram‐Positive Infections: A Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 40:5, pages 469-478.
Crossref
Crossref
Matthew W. McCarthy, Katelyn R. Keyloun, Patrick Gillard, Justin J. Choi, Nicholas Pickell, Ronald Copp & Thomas J. Walsh. (2019) Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial. Infectious Diseases and Therapy 9:1, pages 53-67.
Crossref
Crossref
Bruce M. Jones, Roby Hersey, Colleen Taylor & Christopher M. Bland. (2019) Evaluation of dalbavancin on length of stay in acute bacterial skin and skin structure infections. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2:5, pages 477-481.
Crossref
Crossref
Joseph S. WallinsKaren M. Cajiao, Killian J. McCarthy, Alisson Estrada-Roman & Michael C. Gavin. (2019) Impact of an Outpatient Cardiology-managed Urgent Access and Observation Unit on Hospital Admissions. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 18:3, pages 113-120.
Crossref
Crossref
Taylor Morrisette, Matthew A Miller, Brian T Montague, Gerard R Barber, R Brett McQueen & Martin Krsak. (2019) On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections. Journal of Antimicrobial Chemotherapy 74:8, pages 2405-2416.
Crossref
Crossref
Jason C Gallagher. (2019) Omadacycline: A Modernized Tetracycline. Clinical Infectious Diseases 69:Supplement_1, pages S1-S5.
Crossref
Crossref
Taylor Morrisette, Matthew A Miller, Brian T Montague, Gerard R Barber, R Brett McQueen & Martin Krsak. (2019) Long-Acting Lipoglycopeptides: “Lineless Antibiotics” for Serious Infections in Persons Who Use Drugs. Open Forum Infectious Diseases 6:7.
Crossref
Crossref
Urania Rappo, Pedro L. Gonzalez, Sailaja Puttagunta, Karthik Akinapelli, Katelyn Keyloun, Patrick Gillard, Yan Liu & Michael W. Dunne. (2019) Single-dose dalbavancin and patient satisfaction in an outpatient setting in the treatment of acute bacterial skin and skin structure infections. Journal of Global Antimicrobial Resistance 17, pages 60-65.
Crossref
Crossref
Philip A Giordano, Jason M Pogue & Sue Cammarata. (2019) Analysis of Pooled Phase III Efficacy Data for Delafloxacin in Acute Bacterial Skin and Skin Structure Infections. Clinical Infectious Diseases 68:Supplement_3, pages S223-S232.
Crossref
Crossref
Keith S Kaye, Lindsay A Petty, Andrew F Shorr & Marya D Zilberberg. (2019) Current Epidemiology, Etiology, and Burden of Acute Skin Infections in the United States. Clinical Infectious Diseases 68:Supplement_3, pages S193-S199.
Crossref
Crossref
William O’RiordanSinikka GreenJ. Scott OvercashIvan PuljizSymeon MetallidisJ. GardovskisLynne Garrity-RyanAnita F. DasEvan TzanisPaul B. EckburgAmy ManleyStephen A. VillanoJudith N. SteenbergenEvan Loh. (2019) Omadacycline for Acute Bacterial Skin and Skin-Structure Infections. New England Journal of Medicine 380:6, pages 528-538.
Crossref
Crossref
Sefollah Alaei, Fatemeh Alhani & Hassan Navipour. (2018) The financial transaction between counseling and nursing care service centers (CNCSCs) and their clients: a qualitative study. BMC Health Services Research 18:1.
Crossref
Crossref
Kimberly C. Claeys, Evan J. Zasowski, Abdalhamid M. Lagnf, Noor Sabagha, Donald P. Levine, Susan L. Davis & Michael J. Rybak. (2018) Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting. Infectious Diseases and Therapy 7:4, pages 495-507.
Crossref
Crossref
Khine Tun, James F. Shurko, Laurajo Ryan & Grace C. Lee. (2018) Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012. PLOS ONE 13:11, pages e0206893.
Crossref
Crossref
William O’Riordan, Alison McManus, Juri Teras, Ivan Poromanski, Maria Cruz-Saldariagga, Megan Quintas, Laura Lawrence, ShuJui Liang, Sue Cammarata, Gustavo Jorge ChaparroSrSr, Natalia Elizabeth Frassone, Graciana Morera, Antônio Tarcisio de Faria FreireSrSr, Júlio César Stobbe, Rossen Stoyanov Dimov, Borislav Tzvetanov NinovSrSr, Ivan Poromanski, Petar Rusev, Simeon Simeonov, Georgi Vasilev Todorov, Jorge Manuel Perez GodoySrSr, Jaak Lind, Andres Tein, Jüri Teras, Andrei Uksov, Roland Akhalaia, Erekle Gotsadze, Kakhaber Kashibadze, Jano Vashadze, Katalin Egyud, Zsolt Horváth, Lajos Kemény, Levente Kövágó, Tibor Olah, Yong Kyun ChoSrSr, Seong-Ho Choi, Won Seok Choi, Yong Pill Chong, Min Ja Kim, Shin-Woo Kim, Yeon Sook KimSrSr, Janis Gardovskis, Viktors Lovcinovskis, Maris Nalivaiko, Guntars Pupelis, Eduardo Rodriguez Noriega, Nora Patricia Quintero Pérez, Adrian Camacho Ortiz, Eugen Gutu, Sergiu Revencu, Sergiu Ungureanu, Luis A Camacho Cosavalente, Jaime Ismael Soria Medina, Maria Edelmira Cruz, Oscar Guillermo Pamo Reyna, Pedro Esteban Legua Leiva, Marius Eugen Ciurea, Ion Florea, Carmen Giuglea, Silviu Adrian Marinescu, Silviu Horia Morariu, Remus Ioan Orasan, Petrisor Z Crainiceanu, Yen-Hsu Chen, Yin-Ching Chuang, Sinikka Liisa Green, Alison J McManus, Jeffrey K Kingsley, Loren Miller, Robert Houghton, Verne Leroy Willits, Steven Hugh Mannis, Sheri Stucke, Peter Rives, Eric Hansen, Pietro Giuseppe Pecci, Hermilito L Villar, Richard Beasley, Philip A Giordano, John Pullman, Chok Ping Wan, Shaukat Shah, Godson I Oguchi, Thomas M Birch, Sadi M Dar, Barr L Baynton & Melanie Hoppers. (2018) A Comparison of the Efficacy and Safety of Intravenous Followed by Oral Delafloxacin With Vancomycin Plus Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections: A Phase 3, Multinational, Double-Blind, Randomized Study. Clinical Infectious Diseases 67:5, pages 657-666.
Crossref
Crossref
Christian Koziatek, Sanjay Mohan, Christopher Caspers, Anand Swaminathan & Jordan Swartz. (2018) Experience with dalbavancin for cellulitis in the emergency department and emergency observation unit. The American Journal of Emergency Medicine 36:7, pages 1312-1314.
Crossref
Crossref
Nicholas Black & Jon W. Schrock. (2018) Evaluation of Skin and Soft Tissue Infection Outcomes and Admission Decisions in Emergency Department Patients. Emergency Medicine International 2018, pages 1-7.
Crossref
Crossref
Robert E. Harris, Jessica Richardson, Rosemary Frasso & Evan D. Anderson. (2018) Experiences with skin and soft tissue infections among people who inject drugs in Philadelphia: A qualitative study. Drug and Alcohol Dependence 187, pages 8-12.
Crossref
Crossref
Alessia Savoldi, Anna M. Azzini, David Baur & Evelina Tacconelli. (2018) Is there still a role for vancomycin in skin and soft-tissue infections?. Current Opinion in Infectious Diseases 31:2, pages 120-130.
Crossref
Crossref
Garyphallia Poulakou, Efthymia Giannitsioti & Sotirios Tsiodras. (2017) What is new in the management of skin and soft tissue infections in 2016?. Current Opinion in Infectious Diseases 30:2, pages 158-171.
Crossref
Crossref
Patrick J. Anastasio, Pete Wolthoff, Annmarie Galli & Weihong Fan. (2017) Single-Dose Oritavancin Compared to Standard of Care IV Antibiotics for Acute Bacterial Skin and Skin Structure Infection in the Outpatient Setting: A Retrospective Real-World Study. Infectious Diseases and Therapy 6:1, pages 115-128.
Crossref
Crossref
Nehal Gamal Hashem, Levita Hidayat, Leonard Berkowitz & Veena Venugopalan. (2016) Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool. Journal of Antimicrobial Chemotherapy 71:11, pages 3268-3275.
Crossref
Crossref